The Bradykinin B2 Receptor Agonist (NG291) Causes Rapid Onset of Transient Blood–Brain Barrier Disruption Without Evidence of Early Brain Injury

por Rodríguez-Massó, Sergio R., Erickson, Michelle A., Banks, William A., Ulrich, Henning, Martins, Antonio Henrique
Publicado 2021